Drugs / ALB-PRF
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT06643507 | Apr 2025 → Dec 2026 expected | gingival recession | Cairo University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Alb-PRF | “Albumin-platelet Rich Fibrin (Alb-PRF)” NCT06643507 ↗ |
| Known as | Albumin-platelet Rich Fibrin | “Albumin-platelet Rich Fibrin (Alb-PRF)” NCT06643507 ↗ |